By working synergistically with platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), this platform successfully achieved effective angiogenesis in vivo, demonstrating its great potential for treating ischemic diseases (Park et al., 2021). Here, VEGFA is linked to ischemic disease.